Clinical Trial Update: Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on cryoablation with tirelizumab and bevacizumab in liver-metastatic metastatic breast cancer after multiline therapy; results not disclose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Liver Metastasis

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cryoablation
• Tirelizumab (tirelizumab)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer in the Liver | Phase 2 | Status: UNKNOWN